Navigation Links
Several abstracts on gout reveal true burden of disease and highlight promising new treatments
Date:5/26/2011

A pan-European study of 755 gout patients found that prevalence of self-reported gout was highest in the UK (2.2%) and lowest in France (0.76%). French, German and British gout patients all had lower quality of life scores, and had significant work and social impairment compared to controls (p<0.05 for all comparisons). Interestingly, patients in these countries also had more hypertension, diabetes, congestive heart failure and renal disease (p=0.05) compared to healthy controls.

Abstract Number: FRI0275-HP

Phase III study demonstrates long term efficacy and safety of pegloticase (Krystexxa)

Results of an American study show that 42% of patients treated with pegloticase (8mg every 2 weeks) achieved normal sUA after six months of treatment and of those patients who elected to continue in an open label extension 84% were able to be safely and effectively treated long term (> 2 years). Conclusions from an analysis of these responder patients suggests that subjects who have normalised their sUA after six months on pegloticase (8 mg every 2 weeks) may be able to experience a gap in therapy for as long as 167 days without losing subsequent responsiveness to treatment.

The analysis of data from a 26-week randomised controlled trial (RCT), followed by a 30-month open-label extension (OLE) showed that 90% of these responder patients had complete resolution of tophi at 50 weeks. There were clinically relevant significant reductions in the number of gout flares, tender and swollen joints and improvements in patient-reported outcomes, including pain, physical function and quality of life. There were no remarkable safety concerns with these persistent responders.

Abstract Number: OP0113

Lesinurad and allopurinol combination more effective than allopurinol alone

Researchers from Western and Eastern Europe, Canada, Spain and the USA studied the efficacy and safety of combination treatment with lesinurad and allopurinol in 208 allopurinol-refractory gout patients and found in an intent-to-treat analysis that up to 79% of patients receiving the combination responded to treatment (sUA <6 mg/dL) compared to 25% on allopurinol, the current standard of care, plus placebo.

After four weeks, patients receiving the combination treatment showed up to a 30% reduction in sUA from baseline (allopurinol alone) compared to a 3% increase in sUA for the patients in the allopurinol plus placebo group, and adverse events (AEs) were comparable between groups.

Abstract Number: OP0111

Drinking four or more sugar sweetened beverages increases gout risk four-fold

A study from New Zealand examined the association between gout and sugar-sweetened beverages (including soft-drinks and fruit juices), primarily sweetened with sucrose, in 1,386 people from various ethnic groups.

The results of the study showed that, similar to an association found in US study participants, consuming four or more sugar-sweetened beverages (defined as one can or large glass) was associated with an up to four-fold increase in developing gout across ethnicities. Authors suggest that the association could be due to the effect of fructose on sUA concentrations, through the production of adenosine monophosphate (a nucleotide in RNA) which is converted into uric acid.

Abstract Number: THU0003


'/>"/>

Contact: Rory Berrie
rory.berrie@cohnwolfe.com
44-790-151-3297
European League Against Rheumatism
Source:Eurekalert

Related biology news :

1. Several baffling puzzles in protein molecular structure solved with new method
2. Aware to Introduce Several New Software Products at the Biometrics Consortium Conference
3. Insulin may reduce several inflammatory factors induced by bacterial infection
4. Owners should count calories for obese pets, consider several factors for good health
5. Holding breath for several minutes elevates marker for brain damage
6. Scientists uncover mode of action of enzyme linked with several types of cancer
7. CCNY, CSHL biologists find birdsong of isolates reverts to norm over several generations
8. Research synthesis shines light on several management options after fires in diverse ecosystems
9. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
10. Abstracts for the EORTC-NCI-AACR Symposium in Berlin go up online on Friday, Oct. 29
11. Call for abstracts and registration the EMBO Meeting 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
Breaking Biology News(10 mins):
(Date:5/2/2016)... ... May 02, 2016 , ... F.E.E.D. Co., the Feline ... their revolutionary, veterinarian-designed product for indoor cats. The NoBowl Feeding System replaces the ... food the way nature intended. NoBowls make cats happy and healthy. , Since ...
(Date:4/29/2016)... CO (PRWEB) , ... April 29, 2016 , ... ... addressing the necessary fundamentals to transform technology into a viable company, CereScan’s CEO, ... growth. Mr. Kelley, a recognized leader and mentor in the Denver area ...
(Date:4/28/2016)... , April 28, 2016 ... reports the Company,s CEO  was featured in an ... Enter When VCs Fear To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... magazine is an essential business journal ... from emerging biotechs to Big Pharmas. Their content ...
(Date:4/27/2016)... , ... April 27, 2016 , ... Cambridge Semantics, ... semantic web technology, today announced that it has been named to The Silicon Review’s ... financial services and other markets, Cambridge Semantics serves the needs of end users facing ...
Breaking Biology Technology: